Cycloamycin Capsules

The structure is similar to that of papaverine. Single or continuous administration can increase blood flow to the brain, heart, kidneys and limbs. It can directly relax vascular smooth muscle to dilate blood vessels, and has a selective and sustained dilation effect on the brain, kidneys, blood vessels and coronary arteries, thereby increasing blood flow. The effect is weaker and more lasting than that of papaverine. This product can also promote collateral circulation. It has almost no effect on respiration, heart rate, cardiac output, myocardial oxygen consumption, blood pressure, etc.

The main ingredient and chemical name of this product are: 3,3,5-trimethylcycloethanol-α-phenyl-α-hydroxyacetate

This product is a capsule, the contents are white or off-white amorphous powder

It is used for ischemic cerebrovascular disease, cerebral arteriosclerosis, sequelae of brain trauma, acral artery spasm, acrocyanosis, occlusive endarteritis, inner ear vertigo, etc.

800-1200 mg/day. 100-200 mg each time, 3-4 times a day. After the symptoms improve, the dosage can be reduced to 300-400 mg a day. For cerebrovascular diseases, generally take 200-400 mg each time, 3 times a day.

It can cause nausea, vomiting, loss of appetite, upper abdominal discomfort, and sometimes facial flushing, dizziness, headache, rash, pruritus, dry mouth, palpitations, hypotension, numbness, tremor, tachycardia, sweating, etc.

It is contraindicated for use in patients in the acute stage of severe cerebrovascular accident, pregnant women, and lactating women.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not allowed. Precautions for the elderly: Not yet clear.

Not yet clear.

Keep in dark place and sealed

0.1g

24 months

Jilin Guruite Pharmaceutical Co., Ltd.

• Founded in:

  2005-12-29

• Address:

  No. 4568, Xincheng East Road, Wenhua Street, Ningjiang District, Songyuan City, Jilin Province

• Tax NO.:

  91220701782609573M

• Registered Funds:

  60 million yuan

• Email:

  Log in to view